Kyniska Robotics

What Kyniska Robotics does

Kyniska Robotics SAS is a privately held French medical-technology company founded in 2023 and headquartered in Saint-Martin-d'Hères, in the Grenoble metropolitan area. The company is building a surgical robotic system specifically targeted at sports-medicine procedures — a deliberate narrowing of scope relative to general surgical-robotics platforms, intended to improve surgical precision and outcomes for athletes and active patient populations. Its primary customer persona is orthopedic and sports-medicine surgeons, and its value proposition centers on domain specialization rather than broad-spectrum capability.

The company's commercial offering is currently a single core product, the Kyniska surgical robotic solution, with no separate modules, service lines, or add-on revenue streams disclosed. Distribution, pricing, and go-to-market mechanics are not publicly disclosed, and no regulatory clearances, certifications, patents, or installed-base evidence are referenced in available materials. Kyniska is founder-led under president and publication director Stéphane Lavallée, and is supported by Haventure, which is presented as a venture/hardware accelerator or financial partner rather than a controlling corporate parent. Operating geography is limited to France/Europe.

The revenue model is not articulated: there are no disclosed funding rounds, no capital structure details, and no evidence of commercial sales. The company appears to be in a pre-commercial, development-stage phase, with its near-term strategic posture oriented around building clinical-advisor credibility, securing accelerator-level support, and progressing the surgical robotic platform toward a future regulatory and commercialization pathway.

Name

Kyniska Robotics

Legal name

Kyniska Robotics SAS

Website

https://kyniska-robotics.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Kyniska Robotics SAS, founded in 2023 in Grenoble, France, develops a surgical robotic platform purpose-built for sports-medicine procedures, targeting orthopedic and sports-medicine surgeons serving athletes and active patient populations.

Ownership category

akta.pro rank

Product category

Surgical Robotics Systems

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Surgical robotics
• Sports medicine
• Robotic surgery systems
• Orthopedic robotics
• Medical robotics

Headquarters

HQ city

Saint-martin-d'heres

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Core offering

Kyniska Robotics develops and intends to commercialize a single surgical robotic solution purpose-built for sports medicine procedures. The system combines a robotic-assisted surgical platform with innovative technology aimed at improving precision and clinical outcomes for surgeons treating athletes and active patients, supported by a team of surgeon advisors and technical experts in surgical robotics.

Product overview

Kyniska Robotics offers a single core product: a surgical robotic solution for sports medicine. The company's offering consists of one unified product focused on helping surgeons achieve improved outcomes in sports medicine procedures. No additional modules, add-ons, or separate product lines are referenced in available materials.

Differentiator

Problem solved

Functional benefit

Products and services

• Surgical Robotic Solution for Sports Medicine A surgical robotic system designed specifically for sports medicine procedures, intended to improve surgical precision and outcomes for surgeons treating athletes and active patients. It is the company's core and only marketed product offering.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves4 records

Expansion highlights2 records

Direct peers

• THINK Surgical: THINK Surgical develops TPLAN/TSolution orthopedic surgical robotics platforms for joint replacement, sharing Kyniska's positioning as a focused orthopedic/surgical robotics pure-play.
• Stryker (Mako): Stryker's Mako robotic-arm platform is the dominant orthopedic/sports-medicine surgical robot globally, targeting knee and increasingly hip and shoulder procedures — directly competitive with Kyniska's sports-medicine focus.
• Smith+Nephew (CORI): Smith+Nephew's CORI handheld robotic system is purpose-built for sports-medicine arthroscopy (knee, ACL, meniscus), the closest direct competitor to Kyniska's stated niche.
• Zimmer Biomet (ROSA): Zimmer Biomet's ROSA robotics platform spans knee, hip, and shoulder orthopedic robotics with sports-medicine applications, making it a directly comparable orthopedic surgical robotics incumbent.

Broad incumbents

• Intuitive Surgical: Intuitive Surgical's da Vinci platform defines surgical robotics broadly; while focused on soft tissue, it represents the dominant incumbent benchmark for clinical adoption, regulatory pathway, and commercial scale in surgical robotics.
• Medtronic (Hugo): Medtronic's Hugo robotic-assisted surgery platform is a broad-incumbent entrant in surgical robotics, relevant for Kyniska as a competitor for hospital capital budgets and OR integration partnerships.

Emerging players

• Moon Surgical: Moon Surgical is a European (French) early-stage surgical robotics company building a compact robotic assistant for laparoscopic and soft-tissue procedures — a geography and stage peer with overlapping robotics DNA.
• Virtual Incision: Virtual Incision is an early-stage surgical robotics company developing miniaturized robotic systems for minimally invasive surgery — comparable as a peer-stage emerging surgical robotics pure-play.
• Remedy Robotics: Remedy Robotics is a deep-tech startup building surgical robotic systems with a focus on accessible/niche surgical use cases — an early-stage peer in the surgical robotics landscape adjacent to Kyniska's positioning.

Regional players

• Medicaroid (Hinotori): Medicaroid's Hinotori surgical robot is an Asian (Japan-led) surgical robotics entrant targeting multiple specialties; relevant as a non-US/EU emerging surgical robotics competitor with comparable niche-build ambitions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kyniska Robotics